Ben Ho Park, MD, PHD
Affiliations: | Genetics | Johns Hopkins University, Baltimore, MD |
Google:
"Ben Park"Parents
Sign in to add mentor| Bert Vogelstein | post-doc | Johns Hopkins Medical School (Chemistry Tree) |
Children
Sign in to add trainee| Justin Cidado | grad student | Johns Hopkins | |
| Sarah Croessman | grad student | Johns Hopkins | |
| John Gustin | grad student | 2009 | Johns Hopkins |
| Joseph P. Garay | grad student | 2010 | Johns Hopkins |
| Morassa Mohseni | grad student | 2006-2012 | Johns Hopkins |
| Brian G. Blair | post-doc | Johns Hopkins (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Miranda AX, Kemp J, Davidson B, et al. (2024) Genomic dissection and mutation-specific target discovery for breast cancer hotspot mutations. Biorxiv : the Preprint Server For Biology |
| Foy R, Crozier L, Pareri AU, et al. (2023) Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest. Molecular Cell. 83: 4047-4061.e6 |
| Garcia-Recio S, Hinoue T, Wheeler GL, et al. (2022) Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nature Cancer |
| Wong HY, Sheng Q, Hesterberg AB, et al. (2022) Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease. Nature Communications. 13: 6036 |
| Altwegg KA, Viswanadhapalli S, Mann M, et al. (2022) A first-in-class inhibitor of ER coregulator PELP1 targets ER+ breast cancer. Cancer Research |
| Udden SN, Wang Q, Kumar S, et al. (2022) Targeting ESR1 mutation-Induced transcriptional addiction in breast cancer with BET inhibition. Jci Insight |
| Henry NL, Somerfield MR, Dayao Z, et al. (2022) Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201063 |
| Liu MC, MacKay M, Kase M, et al. (2022) Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer. Jco Precision Oncology. 6: e2100321 |
| Dang DK, Park BH. (2022) Circulating tumor DNA: current challenges for clinical utility. The Journal of Clinical Investigation. 132 |
| Cravero K, Pantone MV, Shin DH, et al. (2022) PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model. Oncotarget. 13: 373-386 |